Announcements Trials
Browse Landscape

Status

Completed 152Recruiting 49Unknown 40Terminated 38Active not recruiting 18Withdrawn 14Not yet recruiting 8Suspended 3No longer available 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1Genitourinary 1

Conditions

Solid Tumors 2Rhabdoid Tumor 2Wilms Tumor 1Solid Tumours 1Solid Tumor, Adult 1Solid Tumor Metastatic Cancer Advanced Cancer 1Solid Tumor 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Pinealoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Mesothelioma, Malignant 1Meningeal Neoplasms 1Medulloblastoma 1Malignant Solid Tumour 1Hepatoblastoma 1Desmoplastic Small Round Cell Tumor 1Chondrosarcoma 1Carcinoma, Renal Cell 1

Interventions

tazemetostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Mesothelioma, Malignant × Other solid neoplasm × Clear all
NCT03874455 2024-03-22

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Ipsen

No longer available
GenitourinaryOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Carcinoma, Renal Cell, Chondrosarcoma, Sarcoma, Sarcoma, Synovial, Rhabdoid Tumor, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡